News

Caregivers will learn strategies to reduce stress, enhance caregiving skills, and improve overall well-being.

NIH-Backed Care Partners Program Supports the Caregivers of People with Alzheimer’s Disease

Historically, physicians have focused concern on people showing early signs of Alzheimer’s disease. Less appreciated, however, is the large burden placed on their caregivers. The goals of the study include reducing caregiver burden, lowering any symptoms of depression among caregivers, and helping people delay the placement of a loved one in an institutional setting.

Read more »

Amanda J. Myers, Ph.D.

Major Alzheimer’s Study Locates New Therapeutic Target

A large, multidimensional study, led by University of Miami Miller School of Medicine researcher Amanda J. Myers, Ph.D., has identified a potential therapeutic target for late-onset Alzheimer’s disease — a protein called HSPA2. The study shows how comprehensive systems approaches can help answer some of the most difficult biological questions.

Read more »

Brain scans were one method used to identify study subjects.

Novel Strategy Shows Promise for Earlier Detection of Alzheimer’s Disease

Finding an effective way to identify people with mild cognitive impairment who are most likely to go on to develop Alzheimer’s disease has eluded researchers for years. But now, a team of researchers led by David Loewenstein, Ph.D., director of the Center for Cognitive Neuroscience and Aging and professor of psychiatry and behavioral sciences, has devised a novel strategy that could do just that.

Read more »

MRI of brain of MS patient. Courtesy of Robert J. Fox, M.D., Cleveland Clinic.

Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

Results from a multi-center clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that the drug ibudilast was better than a placebo at slowing down brain shrinkage. The study, led in Miami by University of Miami neurologist Sylvia Delgado, M.D., also showed that the main side effects of ibudilast were gastrointestinal discomfort and headaches.

Read more »

Sara J. Czaja, Ph.D.

Dr. Sara J. Czaja Steps Down to Direct New Aging Center at Weill Cornell Medicine

After nearly 30 years at the University of Miami, Sara J. Czaja, Ph.D., professor and director of the Center on Aging in the Department of Psychiatry and Behavioral Sciences at the Miller School of Medicine, has accepted a position as professor of medicine in the Division of Geriatrics and Palliative Medicine and director of the new Center on Aging and Behavioral Research at Weill Cornell Medicine in New York.

Read more »